Abstract
The National Chlamydia Screening Programme (NCSP) in England is changing its aim, to “focus on preventing adverse consequences of untreated chlamydia infection…rather than aiming to reduce prevalence”.1 In future, screening tests to detect asymptomatic Chlamydia trachomatis infection will no longer be offered to men younger than 25 years who attend primary care and community health services, but these tests will still be offered to women. The main reason behind this shift in strategy is that, more than 20 years after the start of the plans for the NCSP,2 there is still no clear evidence that widespread testing will reduce chlamydia transmission and have an impact on prevalence and complications.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call